UPCOMING EVENTS

  • CTTACC 2025 / May 4-7, 2025 / Scottsdale, AZ
    CTTACC 2025 / May 4-7, 2025 / Scottsdale, AZ
    This is the sixth in a series of conferences entitled “Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Medicine”. Cellular therapies, adjuncts in resuscitation and novel blood products represent critical areas in transfusion medicine that have the potential to dramatically improve outcomes in trauma patients. Previous conferences have resulted in multiple cross-disciplinary collaborations and grants for pre-clinical studies and clinical trials. KaloCyte is a Silver Sponsor for this event and is presenting a scientific abstract during the poster session.
  • 48th Annual Conference on SHOCK / May 31 - June 3, 2025 / Boston, MA
    48th Annual Conference on SHOCK / May 31 - June 3, 2025 / Boston, MA
    The Annual Conference on SHOCK is a premier event that brings together leading scientists, clinicians, and researchers from around the world to share the latest advancements and innovations in the field. With a diverse and highly motivated audience, the conference offers unparalleled opportunities for sponsors and exhibitors to engage with key opinion leaders and innovators.
  • BIO International Convention / June 16 - 19, 2025 / Boston, MA
    BIO International Convention / June 16 - 19, 2025 / Boston, MA
    The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe. Elaine Haynes will attend with the Maryland State Commerce Department delegation.
  • CTTACC 2025 / May 4-7, 2025 / Scottsdale, AZ
    CTTACC 2025 / May 4-7, 2025 / Scottsdale, AZ
    This is the sixth in a series of conferences entitled “Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Medicine”. Cellular therapies, adjuncts in resuscitation and novel blood products represent critical areas in transfusion medicine that have the potential to dramatically improve outcomes in trauma patients. Previous conferences have resulted in multiple cross-disciplinary collaborations and grants for pre-clinical studies and clinical trials. KaloCyte is a Silver Sponsor for this event and is presenting a scientific abstract during the poster session.
  • 48th Annual Conference on SHOCK / May 31 - June 3, 2025 / Boston, MA
    48th Annual Conference on SHOCK / May 31 - June 3, 2025 / Boston, MA
    The Annual Conference on SHOCK is a premier event that brings together leading scientists, clinicians, and researchers from around the world to share the latest advancements and innovations in the field. With a diverse and highly motivated audience, the conference offers unparalleled opportunities for sponsors and exhibitors to engage with key opinion leaders and innovators.
  • BIO International Convention / June 16 - 19, 2025 / Boston, MA
    BIO International Convention / June 16 - 19, 2025 / Boston, MA
    The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe. Elaine Haynes will attend with the Maryland State Commerce Department delegation.

NEWS

Another Step Closer to Artificial Blood – CBS News.com

Dec 5, 2016

Artificial blood stored as a powder could one day revolutionize emergency medicine and provide trauma victims a better chance of survival. Researchers have created an artificial red blood cell that effectively picks up oxygen in the lungs and delivers it to tissues...

read more

Another Step Closer to Artificial Blood – HealthDay.com

Dec 3, 2016

By Dennis Thompson HealthDay Reporter SATURDAY, Dec. 3, 2016 (HealthDay News) -- Artificial blood stored as a powder could one day revolutionize emergency medicine and provide trauma victims a better chance of survival. Researchers have created an artificial red blood...

read more

CONTACT US

info@kalocyte.com

670 West Baltimore Street
HSRF III, 8th Floor
Baltimore, Maryland 21201

QUICK LINKS

ABOUT US

KaloCyte was founded by a distinguished team of researchers in physiology, bioengineering, and trauma care and is poised to deliver ErythroMer, a dried, bio-inspired artificial red blood cell, to market. ErythroMer is envisioned for use when stored red blood cells are unavailable, undesirable or in short supply. KaloCyte is supported by over $20M in federal grants and investor funding.